Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. - Wikidata - awgldk - TriplyDB

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

http://www.wikidata.org/entity/Q34023024

about

Sex, receptors, and attachment: a review of individual factors influencing response to oxytocin From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention Does the oxytocin receptor (OXTR) polymorphism (rs2254298) confer 'vulnerability' for psychopathology or 'differential susceptibility'? Insights from evolution Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis Oxytocin in the socioemotional brain: implications for psychiatric disorders Prosocial effects of oxytocin in two mouse models of autism spectrum disorders Reversal of social deficits by subchronic oxytocin in two autism mouse models.Modulating social behavior with oxytocin: how does it work? What does it mean?Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.A Role for Oxytocin in the Etiology and Treatment of Schizophrenia.Chronic and acute intranasal oxytocin produce divergent social effects in mice.The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating.Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats.Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism Distinct BOLD Activation Profiles Following Central and Peripheral Oxytocin Administration in Awake Rats.Data extraction and statistical errors: A quantitative critique of Gumley, Braehler, and Macbeth (2014).Potential of Oxytocin in the Treatment of Schizophrenia Maternal contact differentially modulates central and peripheral oxytocin in rat pups during a brief regime of mother-pup interaction that induces a filial huddling preference.Gender differences in oxytocin-associated disruption of decision bias during emotion perception Oxytocin-augmented social cognitive skills training in schizophrenia.The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study Oxytocin and postpartum depression: delivering on what's known and what's not.Potential therapeutic avenues to tackle social cognition problems in schizophrenia.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Peripheral oxytocin is associated with reduced symptom severity in schizophrenia Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia.Developmental perspectives on oxytocin and vasopressin.Minireview: estrogen receptor-initiated mechanisms causal to mammalian reproductive behaviors.Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.Oxytocin administration enhances controlled social cognition in patients with schizophrenia Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders.Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia.Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.

P2860

Q21558399-01B82A4D-EAFF-48E6-BA4D-039387CF7D8E Q26770469-68136A4F-499B-4F30-AE8E-85D92E94A370 Q26824603-16D6CF30-02A2-4DAA-8409-2D6571A169EE Q26851599-DA7CF864-33AC-4212-8473-D0FCAD16576A Q26863704-213B488A-FA85-489A-923E-4D973079058C Q27320111-8971CAA4-CD16-471D-B6B8-B17254D14633 Q28079176-B892B0B0-310F-4FFF-8E14-E90A4CAABC91 Q28386367-52319E68-720C-4E98-8AB0-5806B0110412 Q28394708-E18E115B-EB59-4118-9CB3-BC805C19D244 Q28730932-144B6025-8548-49C6-9546-03DC5ECE6CF6 Q30277149-7B08935B-E360-436F-B97C-B5A4287E12BF Q30408983-EAE721EF-0665-45A0-84BC-0C62A430BF91 Q30415509-22C61B0A-40AE-4A80-84A4-583E5BB94544 Q30427738-7F07332B-BB34-4EF4-9F37-9410E874D44F Q30453929-998B3150-5674-404A-B58D-42040A8DF99A Q30459497-7F314D00-7DFE-40DE-80B9-6242DD308CA8 Q30465634-70972319-D1C0-409A-A147-BBC95D3A2B8B Q30659389-C20D70C2-AA80-4C71-B0A1-38305C2A7F82 Q30665732-BD5AE032-E62A-44DD-8AD0-9E509D43C1AF Q31163872-A966A0A8-739B-482C-88FD-9A5653F2D75F Q33761384-0F9487EE-BBDF-4B07-9508-37F0A2646D35 Q33766976-3BE69C8E-7811-409E-83DB-3EE2C49135D2 Q33861629-F4CF1A35-AE7E-47D9-BCD8-02CFCF0B49AD Q33923629-042BD08B-7151-416C-8E5C-4719CC927668 Q33994774-20193706-9ED4-4C43-83B5-8AC7CCA9C2F4 Q34015372-4405E8F7-E8AB-405F-A6BD-FB2E5D976196 Q34143400-3F5AFE92-86B4-44F4-B7D7-C7924E53CEAA Q34239013-DB90E3E4-3E55-4E48-8DB8-02826053284D Q34274859-995BDE37-1C9E-443D-9779-EDB6CEF31E20 Q34311629-AB304570-47EE-4243-9B21-3B9982C88017 Q34322999-5C8BC95D-0DC3-47B0-A6E4-B989FB193B3F Q34532471-D8392302-6B0A-4659-84A3-C8BC1DEB4BFD Q34675809-5FD057D2-0F08-4864-9453-EABFBF5D1384 Q34697041-3EFB93F9-0BA1-4697-986D-D29117FF8EF3 Q34765148-5C0ECF1B-F2BE-45BE-B9C1-18056B3481E4 Q34790823-7C4F33BE-F904-4513-A9A3-F2326FD5F9CB Q35003945-66C2BA68-D753-499A-A86D-8718E1FD5944 Q35115758-D3427D6A-92F8-4A21-82A0-6E825347D7F8 Q35116515-42BF9D19-FC5E-4DB2-BC0E-31CE974F9404 Q35117441-8779E9C6-DA99-4BAF-9892-60522556F345

P2860

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

http://www.wikidata.org/entity/Q34023024

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@ast

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@en

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@nl

type

label

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@ast

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@en

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@nl

prefLabel

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@ast

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@en

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@nl

P1433

Q34023024-7FDA7777-C13D-4616-BE06-1172543804E5

P1476

Q34023024-145820B1-DAFA-41E6-BF60-3F08BF9BDC89

P2093

Q34023024-0D064059-8375-4635-B559-72987C5BA999

Q34023024-0FBDC703-3E19-4B74-960C-014AF65ECAE0

Q34023024-146DEFA2-57E8-400A-8892-519DF79C58C7

Q34023024-22A018C2-4CB9-4008-823C-9A294BEBBFF4

Q34023024-491141D5-8F34-4B14-8A54-3D163CD020AE

Q34023024-61E484F8-B701-4E48-BB1B-C47A17358B20

Q34023024-67BF587E-48E2-4ACA-B81D-4CBB15BF1483

Q34023024-892C76D3-AEA0-4A9E-A7F6-A36F20A486F4

Q34023024-AE3A5BC9-6104-4C3C-8AF2-07D6A7FAEA7E

Q34023024-B0E41B29-3CD9-4442-8350-49147B8B9B49

P304

Q34023024-5A93E117-4A0C-4871-8CC8-E2E71E9126B5

P31

Q34023024-56E1B0E5-8706-4A4D-9C40-F1366EE9AF9E

P356

Q34023024-BB6651BD-6F5F-4771-9126-C7F59A6F4692

P407

Q34023024-532AC81B-1CD9-485E-BA00-349CEA6BB735

P433

Q34023024-531250A2-4BAA-4390-AA49-4DB1A96EDE0D

P478

Q34023024-BAB549C5-245C-45FA-B1BC-30BD5D4A4216

P577

Q34023024-0281BE97-FB65-433D-9343-D12F464ABE7B

P5875

Q34023024-DF5C6EAC-5575-4D31-9AA7-0BBF3C2473CE

P698

Q34023024-D60E4837-9B5F-4655-AAB0-758DB4C25543

P921

Q34023024-43D42881-3013-48CF-8F1B-0AE8B9FE0E03

Q34023024-5D8B8F2C-FEC8-40D4-8588-57424FFD6B62

Q34023024-EF57EF95-B002-46D3-A4DC-977FFBE6814F

P356

J.BIOPSYCH.2010.04.039

P1433

Biological Psychiatry

P1476

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

@en

P2093

Allison Hadley

http://www.w3.org/2001/XMLSchema#string

Angel Nguyen

http://www.w3.org/2001/XMLSchema#string

Arpi Minassian

http://www.w3.org/2001/XMLSchema#string

Barbara Galangue

http://www.w3.org/2001/XMLSchema#string

David Feifel

http://www.w3.org/2001/XMLSchema#string

Heather Warlan

http://www.w3.org/2001/XMLSchema#string

James Gonzales

http://www.w3.org/2001/XMLSchema#string

Jason Cooper

http://www.w3.org/2001/XMLSchema#string

Kai Macdonald

http://www.w3.org/2001/XMLSchema#string

Mischelle Lefebvre

http://www.w3.org/2001/XMLSchema#string

P304

678-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2010.04.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113036

http://www.w3.org/2001/XMLSchema#string

P698

20615494

http://www.w3.org/2001/XMLSchema#string

P921